Phacoemulsification Under Topical Anesthesia and Its Complications
1 other identifier
interventional
111
0 countries
N/A
Brief Summary
The purpose of this study is to determine if topical anesthesia is safe for phacoemulsification in eyes with comorbidities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Jan 2006
Longer than P75 for phase_1
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2011
CompletedFirst Submitted
Initial submission to the registry
April 7, 2011
CompletedFirst Posted
Study publicly available on registry
June 27, 2011
CompletedJune 27, 2011
March 1, 2011
5.2 years
April 7, 2011
June 24, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Postoperative events
To describe any postoperatives events in a phacoemulsification surgery under topical anesthesia
12 months
Study Arms (1)
Topical anesthesia
OTHERInterventions
Eligibility Criteria
You may qualify if:
- patients with cataract with a visual acuity less than 0.8
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 7, 2011
First Posted
June 27, 2011
Study Start
January 1, 2006
Primary Completion
April 1, 2011
Study Completion
April 1, 2011
Last Updated
June 27, 2011
Record last verified: 2011-03